GLP-1 agonist medications such as Ozempic and Wegovy are in high demand, largely due to their effectiveness at assisting weight loss. According to a recent study in JAMA, these medications may ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.